25 Stocks Moving in Monday's Pre-Market Session

Gainers

• Verona Pharma plc VRNA rose 58.6% to $9.45 in pre-market trading. Verona Pharma reported primary endpoint met at all doses in 4 week Phase 2b COPD study with nebulized ensifentrine on top of tiotropium therapy.
• CounterPath Corporation CPAH shares rose 24.5% to $4.88 in pre-market trading after climbing 304.12% on Friday.
• Enlivex Therapeutics Ltd. ENLV rose 19.4% to $10.03 in pre-market trading.
• Invitae Corporation NVTA rose 13% to $18.90 in pre-market trading. Invitae said it generated revenue of $216 million in 2019, up more than 45% versus the $147.7 million in 2018.
• Safe-T Group Ltd SFET rose 10.4% to $3.41 in pre-market trading. Safe-T Group expects FY 2019 revenue of $3.27 million-$3.37 million, and Q4 revenue of $1.1 million-$1.2 million.
• At Home Group Inc. HOME rose 10.2% to $5.60 in pre-market trading after the company raised its Q4 guidance.
• Amarin Corporation plc AMRN rose 9.5% to $20.75 in pre-market trading. Amarin reported the launche of True To Your Heart, a campaign to educate people on persistent cardiovascular risk.
• ObsEva SA OBSV rose 8.5% to $3.85 in pre-market trading. ObsEva and Yuyuan BioScience Technology announced sublicense agreement to develop and commercialize Nolasiban in the People's Republic of China.
• Jumei International Holding Limited JMEI shares rose 8.3% to $18.88 in pre-market trading after falling 5.78% on Friday.
• Ballard Power Systems Inc. BLDP rose 7.2% to $9.72 in pre-market trading after gaining 5.59% on Friday.
• Edesa Biotech, Inc. EDSA shares rose 6.8% to $3.85 in pre-market trading after surging 13.40% on Friday.
• Cyclerion Therapeutics, Inc. CYCN rose 6.7% to $3.64. Cyclerion Therapeutics is likely to release Phase 1 data for IW-6463 from the study of healthy volunteers at the JPMorgan Healthcare Conference.
• Axsome Therapeutics, Inc. AXSM rose 6.4% to $94.48 in pre-market trading. Axsome Therapeutics entered into an exclusive license agreement with Pfizer for Pfizer's reboxetine clinical and nonclinical data and for new Phase 3 esreboxetine product candidate.
• Axovant Gene Therapies Ltd. AXGT rose 6.4% to $5.30 in pre-market trading after the company reported 'positive' 12-month data on AXO-Lenti-PD and issued updates across gene therapy pipeline programs.
• NIO Limited NIO rose 5.7% to $3.71 in pre-market trading.
• Ligand Pharmaceuticals Incorporated LGND rose 5.4% to $97.98 in pre-market trading.
• Beyond Meat, Inc. BYND shares rose 4.1% to $100.00 in pre-market trading. Chinese plant-based meat substitute founder Vince Lu said entrance of Beyond Meat, Impossible Foods to China can raise the exposure of plant-based foods in the country.
• FinVolution Group FINV rose 4% to $2.65 in pre-market trading.
• OncoCyte Corp OCX rose 3% to $2.73 in pre-market trading after the company announced plans to acquire Insight Genetics for $12 million.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Stage Stores, Inc. SSI fell 31.7% to $5.00 in pre-market trading after the company reported a 1.4% year-over-year rise in its holiday same-store sales. The company said it expects 2019 earnings to be $25 million-$30 million below the low end of its previously given guidance range.
• Cellect Biotechnology Ltd. APOP fell 8.7% to $2.85 in pre-market trading after rising 5.41% on Friday.
• Turtle Beach Corporation HEAR fell 7.5% to $7.90 in the pre-market trading session.
• Cyclacel Pharmaceuticals Inc CYCC fell 4.4% to $0.88 in pre-market trading after the company announced it received a notice of delisting or failure to satisfy a continued listing rule or standard.
• Schlumberger Limited SLB fell 4.4% to $38.10 in pre-market trading.
• Exelixis, Inc. EXEL fell 3.4% to $17.69 in pre-market trading. Exelixis projects FY 2019 revenue of $972 million and Q4 revenue of $245 million.